The global neurosurgery devices market is projected to reach an approximate value of USD 13.9 billion by 2025, growing at a CAGR of 9.8%. Increasing prevalence of neurodegenerative disorders, growing adoption of minimally invasive surgeries, rapidly increasing geriatric population across the globe are factors driving the neurosurgery devices market.
Request for Sample PDF @ https://www.adroitmarketresearch.com/contacts/request-sample/1492
Adroit Market Research report on global neurosurgery devices market gives a holistic view of the market from 2015 to 2025, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2015 to 2017, with the base year of estimation as 2018 and forecast from 2019 to 2025. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global neurosurgery devices market have been studied in detail.
Neurosurgery devices are majorly used in the diagnosis and treatment of neurological disorders of the spinal cord, peripheral nervous systems and brains. Rapidly increasing neurodegenerative conditions such as Parkinson’s disease, Alzheimer’s disease, neuropathic pain, brain tumors is likely to fuel the demand for neurosurgery devices in the future. For instance, Parkinson’s disease is the second most common neurodegenerative condition after Alzheimer’s disease affecting 10 million people globally. It is a progressive neurological condition that causes stiffness, slowness and tremors due to the decrease in dopamine production in the brain. Thus, rapid increase in prevalence of Parkinson’s disease fuels the demand for deep brain stimulation therapy.
Access Complete Report @ https://www.adroitmarketresearch.com/industry-reports/neurosurgery-devices-market
Moreover, increase in geriatric patient pool susceptible to neurological disorders along with rapidly growing demand for minimally invasive surgeries owing to faster recovery, shorter hospital stay and reduced costs is expected for robust market expansion in the coming few years.
The global neurosurgery devices market has been segmented based on product, application, and region. Based on product, the global neurosurgery devices market is categorized into neuromodulation devices and neuroendoscopy devices. Neuromodulation devices are further categorized into internal and external neuormodulation devices. Internal neuromodulation devices are sub-categorized into spinal cord stimulation devices, deep brain stimulation devices, and others. Neuromodulation devices grabbed dominant share of the global market in 2018. Application-wise, the global neurosurgery devices market is segmented into spinal cord stimulation applications, deep brain stimulation application applications and neuroendoscopy applications. Spinal cord stimulation applications is segmented into chronic pain, failed back surgery syndrome, and ischemia. Deep brain stimulation applications include Parkinson’s disease, tremors, depression, and others. Neuroendoscopy applications segment is categorized into transnasal, intraventricular, and transcranial neuroendoscopy. Parkinson’s disease segment of the deep brain stimulation application dominated the global neurosurgery devices market in 2018 owing to rapid increase in prevalence of the disease along with launch of novel devices for the treatment of the disease.
North America dominated the global neurosurgery devices market in 2018. High prevalence of neurological disorders such as Parkinson’s disease, brain tumors, Alzheimer’s disease, spinal cord injuries, neuropathic pain in the region is a key factor likely to drive the growth of the market in the next few years. According to Alzheimer’s Association, approximately 5.8 million Americans were living with Alzheimer’s disease in 2019. Rapidly growing elderly population in the U.S. is further expected to increase its prevalence. However, Asia Pacific neurosurgery devices market is anticipated to grow at a rapid pace over the forecast period.
Major players operating in the global neurosurgery devices market include Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Karl Storz GmbH & Co. KG, Ackermann Instrumente, Nevro Corporation, Adeor Medical, Machida Endoscope Co., Ltd., Integra LifeSciences Corporation, and Hangzhou Hawk Optical Electronic Instruments among others.
Make an Enquire to Buy this Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1492
Key Segments of the Global Neurosurgery Devices Market
Product Overview, 2015-2025 (USD Million)
Neuromodulation Devices
Internal Neuromodulation Devices
Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Others
External Neuromodulation Devices
Neuroendoscopy Devices
Application Overview, 2015-2025 (USD Million)
Spinal Cord Stimulation Applications
Chronic Pain
Ischemia
Failed Back Surgery Syndrome (FBSS)
Deep Brain Stimulation Applications
Parkinson’s Disease
Tremor
Depression
Others
Neuroendoscopy Applications
Transnasal Neuroendoscopy
Intraventricular Neuroendoscopy
Transcranial Neuroendoscopy
Regional Overview, 2015-2025 (USD Million)
North America
U.S.
Canada
Europe
Germany
United Kingdom
France
Rest of Europe
Asia Pacific
China
Japan
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Contact Us:
Ryan Johnson
Account Manager - Global
3131 McKinney Ave Ste 600 Dallas, TX 75204, U.S.A
+1 210-667-2421
Email ID: [email protected]
North America will continue to be the Leading Market for Neuropathic Pain over the Forecast Period (2016–2024)
According to a recent study conducted by RRI, the global market for neuropathic pain is expected to reflect a CAGR of over 5% during the forecast period (2016–2024). In 2015, the market was valued at over US$ 5 Billion and is estimated to stand at US$ 8.3 Billion by 2024 end.
Report For Report Sample with Table of Contents@https://www.researchreportinsights.com/report/sample/110114956/Neuropathic-Pain-Market
Factors such as increasing prevalence of chronic disorders including cancer and diabetes, introduction of newer modalities of receiving neuropathic pain treatment, growing number of pain management service providers and higher demand for neuropathic pain treatment drugs are expected to support the growth of neuropathic pain market globally. Further, arrival of various new medications for neuropathic pain treatment in the market, increasing patient awareness on the availability of advanced neuropathic pain therapeutics and rising demand for generic drugs are additional factors expected to drive the market growth. Moreover, pharmaceutical companies are actively focusing on developing enhanced drugs to cater to the requirement of patients with neuropathic disorders. In contrast to all of that, adverse side effects of steroids and opioids coupled with high cost of branded drugs may act as impediments for the global market of neuropathic pain.
Based on drug class, the global market for neuropathic pain has been segmented into anticonvulsants, tricyclic antidepressant, opioids, local anaesthesia, steroids, and others. Anticonvulsants drug is anticipated to be the largest segment of the market, reflecting a CAGR of over 6% during the forecast period. Minimum risk of side effects is a major factor driving the demand for this segment. By the end of 2024, the segment is estimated surpass market valuation of over US$ 3 Billion. Tricyclic antidepressant drugs are also gaining popularity amongst the physicians and patients and the segment is expected to witness a sound growth during the forecast period.
By indication, the market has been segmented into chemotherapy induced peripheral neuropathy, diabetic neuropathy, and others. Diabetic Neuropathy segment accounts for the largest share of the market. By the end of 2016, the segment is anticipated to account for nearly 47% share of the market in terms of value. On the other hand, chemotherapy induced peripheral neuropathy indication is projected to account for over 42% share of the market in revenue by 2016 end.
Request For Report Discount@https://www.researchreportinsights.com/report/discount/110114956/Neuropathic-Pain-Market
By region, the global market for neuropathic pain has been segmented into Asia Pacific North America, Europe, Latin America and the Middle East & Africa. North America is anticipated to be the most lucrative market for neuropathic pain, account highest share of the market in terms of value. The market in the region is expected to expand at a CAGR of over 5% during the forecast period. This is primarily due to a strong distribution network and presence of advanced healthcare infrastructure and major players of the market in the region.
Vendor News
Key players operating in the global market for neuropathic pain include Bristol Myers Squibb, Depomed, Inc., GlaxoSmithKline PLC, Pfizer, Inc., Sanofi S.A., Eli Lily and Company, Baxter Healthcare Corporation, Biogen Idec, and Johnson & Johnson Services, Inc. Most of these pharmaceutical companies are actively focusing on developing enhanced medication for treat neuropathic pain and other disorders in order to strengthen their presence in the global market for neuropathic pain.
Summary: Global market for neuropathic pain is expected to surpass market valuation of US$ 8 Billion by the end of 2024
Report Analysis@https://www.researchreportinsights.com/report/rd/110114956/Neuropathic-Pain-Market
Autoinjectors are easy-to-handle and cost-effective medical devices that can be used by patients, caregivers, and even untrained personnel to deliver a dose of a particular drug.
Autoinjectors are used by patients to manage autoimmune diseases and chronic diseases.
They are used for a wide range of indications such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724According to the new market research report “Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023", published by MarketsandMarkets™, The global Autoinjectors Market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023).The key factors driving the growth of this market include the growing prevalence of targeted therapies such as rheumatoid arthritis and multiple sclerosis, rising incidence of anaphylaxis, and increasing number of regulatory approvals.Use of autoinjectors in the treatment of rheumatoid arthritis drives the global autoinjectors marketRheumatoid arthritis (RA) is a chronic, systemic, inflammatory autoimmune disease that affects connective tissues.
It causes joints to swell and can result in pain, stiffness, and progressive loss of function.
According to the CDC, an estimated 43.7 million adults (22.7% of the total population) in the US annually are affected by some form of arthritis, RA, gout, lupus, or fibromyalgia.What Drives the Market?1.
Growing prevalence of targeted therapies2.
9th September 2019: Cable Ties Market is expected to display higher growth rate over the upcoming years.
Rapid surge in the market is credited to the rising demand from food & beverages industry, and retail sector.
Development of metal detectable cable ties is expected to drive the growth of the market over the forecast period.
Globally, cable ties market is predicted to generate massive revenue over the forecast period, providing numerous opportunities for industry participants to invest in research and development of cable ties.Growing adoption of metal as well as nylon cable ties from pharmaceutical sector is anticipated to boost the demand of cable ties over the forecast period.
Different types of cable ties such as counting zip tie, wire tie, zipper tie, wire wrap, hose tie, rat belt, and mouse belt are gaining popularity among end-use industries in the past few years.
Use of cable ties for wide range of application ranging from bundling of cables to flameproof applications is estimated to amplify market value for cable ties in the upcoming years.Request Sample Copy @ https://www.millioninsights.com/industry-reports/cable-ties-market/request-sampleCable ties are mostly less expensive, ease of use, and ubiquitous, thus finding application in various industries.
This report studies the global market size of Chronic Low Back Pain Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chronic Low Back Pain Treatment in these regions.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
Market size split by Region
Rest of Central & South America
Do Inquiry Before Accessing Global Chronic Low Back Pain Treatment Market Report at https://www.orbisresearch.com/contacts/enquiry-before-buying/2363719 .
Focuses on the key global Chronic Low Back Pain Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
The report delivers the challenges in front of the Neuromodulation Devices Market that allows the better understanding of the market and provides the lucrative opportunities that are available.
Analyst has studied the current market scenario while concentrating on the new business objectives.
The analysis provides demands for the future, besides the opportunities that are available for individual.
Study focuses on industry chain analysis, upstream and downstream raw material suppliers, key players, production process analysis, cost analysis, market distribution channels and major downstream buyers.Access sample report @ https://www.profsharemarketresearch.com/inquiry/neuromodulation-devices-market-report-inquiry/The Neuromodulation Devices Market Report delivers analysis of various organizations, affiliation and new businesses.
Research furthermore consolidates impact of government regulations and standards over the market.Research analysis covers historical data from the year 2015 to 2019,In addition to this report considers 2021-28 as the forecast year.
This helps manufacturers and clients understand the past trends and analyze the future trend.
Diabetes can be described as a disease, which is marked by high levels of blood glucose resulting from defects in insulin production and insulin action. The disease has become a global epidemic leading to serious complications and ultimately resulting in premature death. Diabetes affects several organs of the body including eyes, kidneys, heart. However, it has been observed that the feet in particular are affected due to damage done to the nerves without immediate/early detection. People suffering from diabetes suffer from feet ulceration that results are usually associated with high treatment expenses.
The global diabetic shoes market is expected to witness a steady growth during the forecast period due to the increasing incidence of diabetes globally. Rising skin related problems in the feet due to diabetes is another reason that is triggering the demand for diabetic shoes. The physicians prescribe diabetic footwear to the patients suffering from diabetes in order to prevent all feet related complications. Owing to high level of comfort and convenience of wearing the diabetic shoes, the global market is expected to grow steadily throughout the forecast period.
Get Sample Copy Of The Report@ https://www.trendsmarketresearch.com/report/sample/3678
In order to get a better understanding of the global diabetic shoes market, a key trends analysis has been included for all the segments. In addition, the market players in the diabetic shoes market have also been profiled. The leading players in the market include. Aetrex Worldwide, Inc. (New Jersey, US State), PodartisSrl. (Montebelluna, Italy), Etonic Worldwide LLC (New York, U.S), Dr. Comfort, LLC. (Wisconsin, U.S.), Advance Diabetic Solution (Georgia, U.S.A), Apex Foot Health Industries LLC ( New York, U.S.A), Dr Zen Products, Inc. (Florida, U.S.A.), DARCO International, Inc (West Virginia, U.S.A), Orthofeet Inc.( New Jersey, U.S.A.) and Drew Shoe Corporation. (Ohio, U.S.A ) among others.
Later on, it was seen that foot has become a complex biomechanical and anatomical structure. Therefore, a complete study of the feet was essential in order to make a diabetic shoe in order to prevent the foot injury. Therapeutic or diabetic shoes are specifically designed to reduce the problems in the feet of the person suffering from diabetes. Diabetes create changes in the skin of the foot due to the damaged nerves, which are no longer functional and prevents moisture and oil secretions. Increasing awareness about the presence of diabetic shoes in the market and the increasing need to lead a healthy lifestyle is one of the key factors propelling the growth of the diabetic shoes market across the globe.
Global Diabetic Shoes market can be segmented as follows;-
§ Global Diabetic shoes Market, by Distribution Channel
• Online Stores
• Specialty Stores
• Shoes Stores
• Departmental Stores
• Super Market & Hyper Market
§ Global Diabetic Shoes Market, by End Use
• Women
• Men
§ Global Diabetic Shoes Market, by Geography
• North America
• U.S.
• Rest of North America
• Europe
• U.K.
• Germany
• France
• Italy
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of APAC
• Middle East
• U.A.E.
• Saudi Arabia
• Qatar
• Kuwait
• Oman
• Rest of Middle East
• Africa
• South Africa
• Rest of Africa
• Latin America
• Brazil
• Rest of Latin America
Report For Sample with TOC@ https://www.trendsmarketresearch.com/report/requesttoc/3678
Diabetic footwear is prescribed by physicians to reduce the complications of a person suffering from diabetes. The consumers must be aware that the diabetic shoe matches the size of the foot and also the shoe has enough room for the toes at the sides and front as well as the top so that the pressure of the shoe are not felt. People with diabetes are highly prone to disrupted blood circulation to the foot resulting due to nerve damage. Disrupted blood circulation results to loss of sensation in the foot, thus causing wounds or ulcers that take a fair amount of time to heal. However, lack of awareness among the consumers regarding the benefits of diabetic shoes is restraining the global diabetic shoes market. Moreover, increasing brand presence and roles of e-commerce are generating opportunities to the diabetic shoes market in recent years and this growth is expected to boost the global diabetic shoes market during the forecast period.
However, diabetic shoes, although act as a convenience for the patients suffering from diabetes, they however, does not help reduce the same. Diabetic shoes are used to comfort the consumers inducing proper blood circulation compared to a patient wearing a regular shoe. Consumers largely resort to the consumption of medicines for treating diabetes and various other alternatives, which is why a large portion of the diabetic population refrain themselves from purchasing diabetic shoes, which in turn is a major factor hindering the growth of the diabetic shoes market at present. Moreover, the price of diabetic shoes are on the higher end which another reason that is refraining the consumers falling in the low and middle income category from purchasing diabetic shoes. This is another reason for the consumers to stick to medicinal treatment and related treatments instead of diabetic shoes. However, with rising awareness, the impact of this restraint is expected reduce during the forecast period.
Moreover, in this report the study provides different countries included in different regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America includes the U.S. and Rest of North America. U.K., Germany, Russia, Italy, France and Rest of Europe included in Europe. China, India, Japan and Rest of Asia Pacific included in Asia Pacific diabetic shoes market. In addition, Middle East includes country such as UAE, Saudi Arabia, Qatar, Kuwait, Oman and Rest of Middle East. Africa includes South Africa and Rest of Africa. Latin America comprise of countries such as Brazil and Rest of Latin America.
Report Analysis@ https://www.trendsmarketresearch.com/report/diabetic-shoes-market
One Vincent Square
Westminster, London SW1P 2PN
United Kingdom Phone: +442033221521
Email: [email protected]
Website: https://www.trendsmarketresearch.com
